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Research
Omega-3 Fatty Acid Supplementation Appears to Attenuate Particulate
Air Pollution–Induced Cardiac Effects and Lipid Changes in Healthy
Middle-Aged Adults
Haiyan Tong,1 Ana G. Rappold,1 David Diaz-Sanchez,1 Susan E. Steck,2 Jon Berntsen,3 Wayne E. Cascio,1
Robert B. Devlin,1 and James M. Samet 1
1Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection
Agency, Research Triangle Park, North Carolina, USA; 2Department of Epidemiology and Biostatistics, University of South Carolina,
Columbia, South Carolina, USA; 3TRC Environmental Corporation, Raleigh, North Carolina, USA

Background: Air pollution exposure has been associated with adverse cardiovascular health effects.
Findings of a recent epidemiological study suggested that omega-3 fatty acid (fish oil) supplementation blunted cardiac responses to air pollution exposure.
Objectives: We conducted a randomized, controlled exposure study to evaluate the efficacy of fish
oil supplements in attenuating adverse cardiac effects of exposure to concentrated ambient fine and
ultrafine particulate matter (CAP).
M ethods : Twenty-nine healthy middle-aged participants (mean, 58 ± 1 years of age) were
supplemented in a randomized, double-blinded manner with 3 g/day of either fish oil or olive oil
for 4 weeks before sequential chamber exposure to filtered air and CAP (mean mass concentration 278 ± 19 µg/m3) for 2 hr. Cardiac responses were assessed by comparing time and frequency
domain changes in heart rate variability (HRV) and electrocardiographic repolarization changes
measured before, immediately after, and 20 hr after exposure. Changes in plasma lipids were also
evaluated at these time points.
R esults : Fish oil supplementation appeared to attenuate CAP-induced reductions in highfrequency/low-frequency ratio, as well as elevations in normalized low-frequency HRV and prolongation of the QT interval corrected for heart rate (QTc). Very low-density lipoprotein and
triglyceride concentrations increased significantly immediately after exposure to CAP in participants
supplemented with olive oil, but not in those supplemented with fish oil.
Conclusions: Exposure of healthy middle-aged adults to CAP for 2 hr induced acute cardiac and
lipid changes after supplementation with olive oil, but not fish oil. Our findings suggest that omega-3
fatty acid supplements offer protection against the adverse cardiac and lipid effects associated with air
pollution exposure.
Key words: cardiac effect, controlled exposure, lipid change, middle-aged healthy human volunteers, omega-3 fatty acid, particulate matter air pollution. Environ Health Perspect 120:952–957
(2012). http://dx.doi.org/10.1289/ehp.1104472 [Online 19 April 2012]

Ambient air pollution exposure is a major
environmental risk to human health. The
World Health Organization (WHO) has
estimated that air pollution causes approximately two million deaths per year worldwide
(WHO 2011), and the number is climbing.
Epidemiological and experimental studies have demonstrated positive associations
between adverse cardiopulmonary effects and
acute and chronic exposure to levels of ambient air pollution currently found in major
metropolitan areas [Brook et al. 2010; U.S.
Environmental Protection Agency (EPA)
2009]. Short-term elevations in ambient particulate matter (PM) concentrations are associated with acute coronary syndrome, stroke,
venous thrombosis, arrhythmia, and worsening of heart failure, particularly in certain
at-risk populations (U.S. EPA 2009). Cohort
studies have reported associations between
PM exposure and modulation of the cardiac
autonomic nervous system input leading to
alterations in heart rate variability (HRV)
(Gold et al. 2000; He et al. 2011; Pope
et al. 2004). Our previous controlled human
exposure studies have shown that concentrated ambient PM exposure changed HRV
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in healthy adults (Devlin et al. 2003; Samet
et al. 2009). Previous studies have also linked
PM exposure with elevated blood lipid levels
in both humans and animals (Sun et al. 2005;
Yeatts et al. 2007).
Ambient PM is a complex mixture of
particles of varying size that are classified as
coarse (PM 2.5–10; 10 µm > PM > 2.5 µm
in aerod ynamic diameter), fine (PM 2.5;
PM < 2.5 µm), and ultrafine (PM0.1; PM
< 0.1 µm) particles. The strongest associations between adverse health effects and particulate air pollution are observed with PM2.5
(Schwartz et al. 1996). However, PM0.1 is not
routinely measured at state monitoring sites
nor is it homogenously dispersed throughout
an airshed, making it difficult to ascertain the
toxicity of these particles in epidemiological
studies. However, clinical and toxicological
studies have reported that PM0.1 can pass
through the lung epithelial cell barrier and
enter the circulatory system, where it may
directly affect the function of cells or organs
(Brook et al. 2010; Nemmar et al. 2004).
Therefore, in this study, participants were
exposed to a combination of concentrated
PM2.5 and PM0.1 ambient air particles (CAP).
volume

Although air pollution regulations have
resulted in dramatic decreases in PM levels
over the past few decades, tens of millions of
persons in the United States are still exposed
to levels of PM that are higher than the current U.S. EPA standards (U.S. EPA 2009).
If dietary supplements or pharmacological
agents can blunt the adverse health effects of
air pollution exposure, populations residing
in highly polluted areas might be afforded
some protection. A number of studies conducted over the last three decades have shown
that the omega-3 polyunsaturated fatty acids
(n‑3 FA), eicosapentaenoic acid and docosahexaenoic acid (DHA), can reduce the risk of
cardiovascular events after myocardial infarction (O’Keefe et al. 2006; Saravanan et al.
2010) as well as reduce atrial fibrillation recurrences in patients with persistent atrial fibrillation (Nodari et al. 2011). In general, n‑3 FA
have several potentially cardiop rotective
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benefits, including suppression of arrhythmias
and modulation of autonomic function in
addition to antithrombotic, anti-inflammatory, and vasodilatory effects (Lee et al. 2009).
Chronically decreased HRV has been used
to predict an increased risk of cardiovascular
morbidity and mortality (Kleiger et al. 1987;
Lahiri et al. 2008; Tsuji et al. 1996), and several studies suggest that the intake of n‑3 FA
may improve autonomic function, including
an increase in vagal activity and baroreflex
sensitivity (Mozaffarian et al. 2008; O’Keefe
et al. 2006).
A recent cohort panel study reported that
the high- and low-frequency (HF and LF)
components of HRV were increased among
elderly participants after n‑3 FA supplementation (Holguin et al. 2005) and that
HRV decline associated with PM2.5 exposure before supplementation was not observed
after n‑3 FA supplementation (Romieu et al.
2005). To our knowledge, no controlled
human exposure studies have been conducted
to investigate the protective effect of n‑3 FA
supplementation against the adverse cardio
vascular effects of air pollutant exposure. We
designed this study to determine whether the
cardiovascular effects caused by exposure to
CAP could be blunted by supplementation
with n‑3 FA, compared with supplementation with oil devoid of n‑3 FA (olive oil). We
report here that supplementation of n‑3 FA
attenuated some adverse effects on autonomic
function, ventricular repolarization, and lipid
changes caused by exposure to CAP in healthy
middle-aged adults.

Methods
Study participants. Twenty-nine participants
ranging from 50 to 72 years of age (mean
58 ± 1 years) were enrolled in the study.
They were nonsmokers for at least 1 year,
with no history of heart disease, uncontrolled
hypertension [mean blood pressure (BP):
123 ± 3/77 ± 2 mmHg], pulmonary disease, diabetes mellitus, hypercholesterolemia,
or active allergy. Participants were not taking β-adrenergic receptor blockers, n‑3 FA,
anti-inflammatory drugs, or antioxidant supplements (such as beta-carotene, selenium,
vitamin C, or vitamin E). All participants
were instructed to refrain from using any pain
medications for 2 weeks before each exposure.
They were also asked to abstain from alcohol
and caffeine and to adhere to a low-fat diet
for 24 hr before exposures. The Biomedical
Institutional Review Board at the University
of North Carolina–Chapel Hill and the U.S.
EPA approved the study protocol, recruitment
materials, and consent forms. All study participants gave informed consent and received
monetary compensation for their participation.
Study design. This study was conducted
from July 2009 to August 2010. All exposures
Environmental Health Perspectives •
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were conducted at the U.S. EPA Human
Studies Facility on the University of North
Carolina–Chapel Hill campus. A diagram of
the study design is shown in Figure 1. Sixteen
participants were assigned to receive 3 g/day
(three 1-g capsules daily) of marine-derived
n‑3 FA (fish oil; FO), and 13 participants
received 3 g/day (three 1-g capsules daily) of
olive oil (OO) for 28 days before the filtered
air exposure day. FO and OO assignments
were made using a randomized, doubleblinded study design. Each participant was
exposed first to filtered air and then to CAP on
the next day. The exposures were conducted
at the same time of the day and same day of
the week. Participants were exposed for 2 hr
through a face mask in an exposure chamber in which temperature and humidity were
controlled. Participants remained at rest in a
seated position throughout the exposure.
The following tests were done on each
participant beginning at approximately
0800 hours (2 hr before exposure to filtered
air): Venous blood was collected (120 min
before exposure); Holter electrodes were
applied and HRV and repolariz ation data
obtained (105 min before exposure); and
brachial artery diameter was measured by
ultrasound (60 min before exposure). The
ultrasound measurements will be reported elsewhere. The same tests were done immediately
after the 2-hr air exposure (Post), and again
the next morning at approximately 0800 hours
(Follow-up). These latter measurements also
served as the preexposure values for the CAP
exposure. At approximately 1000 hours on the
second day, participants were exposed to CAP
for 2 hr. Post and Follow-up measurements
were obtained immediately after exposure and
again beginning at 0800 hours the next morning. The participants wore a portable ambulatory Holter device for the entire 48-hr period
and time domain HRV variables were calculated from the two 24-hr periods.

Dietary supplementations. All participants
were asked to refrain from food containing
n‑3 FA for 2 weeks before and 4 weeks during
the dietary supplementation period. Participants
were also asked to keep 3-day food records during the 2nd and 4th weeks of the supplementation period to assess compliance with the dietary
restrictions. Nutrition Data System for Research
software (version 2011; Nutrition Coordinating
Center, University of Minnesota, Minneapolis,
MN) was used to analyze the food records and
estimate intakes of nutrients that may confound
n‑3 FA measurements. Each 1,000-mg FO
capsule contained approximately 65% n‑3 FA
(410 mg eicosapentaenoic acid and 274 mg
DHA). Each 1,000-mg OO capsule contained
< 1% n‑3 FA (73% oleic acid and 12% palmitic acid). Pharmavite, LLC (Mission Hills, CA)
provided the FO and OO supplements. The
ratios of the major plasma fatty acids were measured at the end of the supplementation period
to determine whether ratios were consistent
with expectations for the FO and OO groups.
Controlled exposure. CAP was generated
as described previously (Samet et al. 2009)
by drawing ambient air from above the roof
of the Human Studies Facility and passing the
air through a 2-stage aerosol Harvard concentrator which produces up to a 30-fold increase
in particle number and mass. Air temperature
and humidity were controlled inside the chamber. The concentration of particles delivered to
the chamber varied with the level of naturally
occurring ambient particles in Chapel Hill air.
However, a particle dilution system was used
to limit the maximal particle concentration
and prevent it from exceeding 600 µg/m3 for
> 6 min at any time during exposure. A face
mask was used to maximize the PM concentration inhaled by the participants. Particle mass
and number concentrations at the chamber inlet
were monitored continuously as described previously (Samet et al. 2009). Filter samples were
also obtained and analyzed for particle mass.

Omega-3 fatty acid restricted diet
Fish oil/olive oil supplementation
2 weeks

Exposures

4 weeks
Week 2

Week 4
Food records

Day 1

Day 2

Filtered air
exposure
Preexposure
measurements

Postexposure
measurements

CAP
exposure
Follow-up
exposure
measurements

Postexposure
measurements

Follow-up
exposure
measurements

Figure 1. Schematic representation of the study design.
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used to calculate frequency domain parameters
of HRV [normalized LF (nLF), normalized
HF (nHF), and the high frequency/low frequency ratio (HF/LF ratio)] and repolarization
parameters. This 30-min regimen was repeated
15 min after exposure to filtered air and CAP
and again the next morning to obtain Post and
Follow-up measurements, respectively. Time
domain HRV parameters {SDNN [standard
deviation of normal to normal (NN) intervals],
PNN50, [fraction of consecutive NN intervals
that differ by more than 50 msec], RMSDD
[the square root of the mean of the sum of
the squares of differences between adjacent
NN intervals]} were calculated from the data
collected over two 24-hr periods (from 2 hr
before air exposure until 0800 hours the next
morning, and from 2 hr before CAP exposure until 0800 hours the next morning). The

Ambulatory electrocardiography (ECG)
measurements. Ambulatory ECG data were
collected for HRV analysis as described
previously (Samet et al. 2009). Briefly,
12-lead Holter ECG data were collected for
approximately 48 hr using a Mortara H12+
Recorder (Mortara Instrument, Milwaukee,
WI). HRV indices in both the time and frequency domains and ventricular repolarization
were calculated from the raw Holter ECG
data using SuperECG software (version 4.0;
Mortara Instrument). HRV was measured to
evaluate the influence of CAP exposure on
the autonomic nervous system control on the
heart. Approximately 90 min before both the
filtered air and CAP exposures, the participants
were asked to recline quietly in a darkened
room for 30 min. During the final 10 min
of the resting period, data were collected and

Table 1. Characteristics of the study participants before supplementation.
Characteristic
Sex (male/female)
Age (years)
Race (white/black)
BMI (m2/kg)
Systolic BP (mmHg)
Diastolic BP (mmHg)
Heart rate (bpm)
Cholesterol (mg/dL)
Total
LDL
VLDL
HDL
Triglycerides (mg/dL)
Glucose (mg/dL)
WBC (× 103/µL)
RBC (× 106/µL)
Platelets (× 103/µL)
Neutrophils (%)
Lymphocytes (%)
Smoking history (no. of participants)
Nonsmokers
Ex-smokers
Current smokers
Medications (no. of participants)
Statin
β-adrenergic receptor blockers
ACE inhibitors
Antidepressants
NSAIDs

FO (n = 16)
4/12
57.4 ± 1.4
10/6
27.6 ± 1.1
122 ± 3
77 ± 2
74 ± 2

OO (n = 13)
4/9
59.3 ± 1.1
11/2
26.3 ± 1.3
123 ± 3
77 ± 2
71 ± 3

p-Value

201 ± 12
117 ± 10
19 ± 2
64 ± 4
97 ± 10
88 ± 3
5.53 ± 0.25
4.45 ± 0.12
245.9 ± 13.6
55.9 ± 2.9
34.9 ± 2.9

214 ± 7
125 ± 9
19 ± 3
70 ± 6
94 ± 14
93 ± 2
5.46 ± 0.39
4.76 ± 0.17
223.3 ± 12.2
55.3 ± 2.7
34.6 ± 2.5

0.41
0.57
0.87
0.46
0.88
0.17
0.88
0.14
0.25
0.88
0.94

11
5
0

11
2
0

1
0
2
2
0

2
0
3
1
0

0.32
0.44
0.92
0.95
0.47

Abbreviations: ACE, angiotensin converting enzyme; BMI, body mass index; HDL, high-density lipoprotein; LDL, lowdensity lipoprotein; NSAID, nonsteroidal antiinflammatory drug; RBC, red blood cells; VLDL, very low-density lipoprotein;
WBC, white blood cells. Data are presented as n or mean ± SE. Two-sample t-test was used to compare the difference
between the FO and OO groups.

Table 2. Percent of total plasma fatty acids after 4 weeks of supplementation with fish oil or olive oil.
Fatty acid
C16:0 palmitic acid
C18:1 oleic acid
C18:2 linoleic acid (LA)
C18:3 linolenic acid (ALA)
C20:4 arachidonic acid (AA)
C20:5 eicosapentaenoic acid
C22:5 docosapentaenoic acid (DPA)
C22:6 docosahexaenoic acid (DHA)

FO (n = 16)
29.78 ± 0.52
15.63 ± 0.66
20.82 ± 0.91
0.56 ± 0.05
7.40 ± 0.46
3.38 ± 0.33
1.07 ± 0.09
1.88 ± 0.16

OO (n = 13)
30.19 ± 0.57
17.44 ± 0.61
20.71 ± 0.55
0.41 ± 0.02
9.07 ± 0.44
0.52 ± 0.04
0.48 ± 0.04
1.65 ± 0.14

p-Value
0.59
0.06
0.92
0.03
0.02
< 0.001
< 0.001
0.51

Data are presented as mean ± SE. Two-sample t-test was used to compare the difference between the FO and OO
groups. Nonabundant fatty acids that did not differ between the two groups are not shown.
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HRV parameters were determined according
to established guidelines (Task Force of the
European Society of Cardiology the North
American Society of Pacing Electrophysiology
Circulation 1996). The QT interval corrected
for heart rate (QTc) was measured to determine the influence of exposure to CAP on
ventricular repolarization. The interval from
the onset of QRS to the peak of the T wave
(QTp), the interval from the peak of the
T-wave to the end of the T-wave (Tp-Te), the
ratio of the transmural dispersion of repolari
zation relative to the total duration of repolari
zation (Tp-Te/QT) were measured to assess
the effects of CAP exposure on spatial dispersion of repolarization.
Blood chemistry and lipids. Venous blood
was collected 2 hr before both the filtered
air and CAP exposures (“Pre”), immediately
after each exposure, and again at 0800 hours
the morning after CAP exposure. LabCorp
(Burlington, NC) performed complete blood
counts, including a differential count and a
lipid panel.
Statistical analysis. To assess changes in
biological end points between the two exposures and among the FO and OO groups,
we used a two-factor (supplement and PM
concentration) mixed effects model with a
subject-specific random intercept. Changes
in HRV, cardiac repolarization, and blood
parameters were assessed at two time points:
immediately and approximately 20 hr after
exposure to CAP and filtered air, denoted
“Post” and “Follow-up” respectively. To control for day-to-day variability, time domain
measures of HRV, cardiac repolariz ation,
blood counts, and lipids were normalized by
dividing the Post and Follow-up values by
the values measured before filtered air exposure (Post/Pre, Follow-up/Pre). Time domain
HRV parameters were calculated once, over a
24‑hr period. Changes are expressed as percent
change after CAP exposure (per 100‑µg/m3
increase in CAP) relative to change after air
exposure. R statistical software (version 2.11.1;
R Developement Core Team; http://www.rp roject.org/) was used for analysis, and a
p-value of < 0.05 was considered significant.

Results
Participants’ characteristics are presented in
Table 1. There were no significant differences
in age, body mass index (BMI), smoking history, medication usage, BP, and serum glucose
or lipids of participants assigned to the FO
and OO groups. Only a small percentage of
each group was taking statins or ACE (angiotensin converting enzyme) inhibitors, and no
participants were taking β-adrenergic receptor blockers. Before supplementation, all participants reported low dietary intakes of foods
rich in n‑3 FA (data not shown). The food
records were collected twice—on the second

120 | number 7 | July 2012 • Environmental Health Perspectives

Omega-3 FA attenuates ambient PM-induced cardiac changes

and fourth week during the supplementation
period—and showed that participants assigned
to FO or OO consumed similar amounts of
dietary n‑3 FA during the supplementation
period [see Supplemental Material, Table 1
(http://dx.doi.org/10.1289/ehp.1104472)].
Plasma FA levels. After the 4-week supplementation period, we compared the ratio of
several plasma fatty acids between the FO and
OO groups. These data are shown in Table 2.
Eicosapentaenoic acid levels were 6.5 times
higher, linolenic acid (ALA) levels 1.4 times
higher, and docosapentaenoic acid (DPA) levels 2.2 times higher in the FO group compared with the OO group. Plasma DHA levels
were not different between the two groups and
levels of arachidonic acid (AA) were significantly lower in the FO group than in the OO
group. There was also a trend for elevation in
plasma levels of oleic acid, the principal fatty
acid in OO, in the OO group compared to
the FO group (p = 0.06).
CAP exposure. Particle concentrations
inside the chamber varied with each exposure,
and were dependant on the outside ambient
air levels [see Supplemental Material, Table 2
(http://dx.doi.org/10.1289/ehp.1104472)].
Ambient PM2.5 concentrations on CAP exposure days ranged from 4.5 to 21.3 µg/m3, with
an average concentration of 11.6 ± 1.0 µg/m3.
CAP concentrations in the chamber ranged
from 83 to 470 µg/m 3 with a mean of
278 ± 19 µg/m3. Particle number concentrations in the chamber ranged from 22,634 to
1,970,748 particles/cm 3 with a mean of
302,515 ± 77,603 particles/cm3. Particle mass
concentrations in the filtered air in the chamber varied from 0 to 0.40 µg/m3, with a mean
of 0.21 µg/m3. There was no significant difference in mean CAP concentrations between the
two groups (301 ± 25 µg/m3 in the FO group;
269 ± 37 µg/m3 in the OO group). Similarly,

nLF
OO, Post
OO, Follow-up
FO, Post
FO, Follow-up
HF/LF

–15

–10

–5

0

5

10

15

Percent change per 100 µg/m3

Figure 2. Effect of CAP exposure on frequency
domain indices of HRV. nLF HRV and HF/LF ratio
were analyzed in the ECG recordings of participants at rest before, immediately after exposure
to filtered air and CAP (Post), and again the next
morning (Follow-up) as described in “Methods.“
Data shown are average changes per 100-µg/m 3
increase in CAP relative to the filtered air and 95%
confidence intervals.
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mean particle number concentrations were not
significantly different (305,800 ± 120,900 particles/cm3 in the FO group; 322,500 ± 97,510
particles/cm3 in the OO group).
HRV and cardiac repolarization. Cardiac
repolarization and HRV frequency domain
parameters measured 2 hr before filtered air
exposure (Pre) were not significantly different
between the FO and OO groups (data not
shown). nLF HRV was significantly increased
in the OO group immediately after CAP exposure, and the change persisted for at least 20 hr
(Figure 2 and Table 3). The HF/LF ratio was
significantly decreased in participants supplemented with OO immediately after CAP exposure, but the decrease was no longer significant
by the next morning (Figure 2). In contrast,
participants taking FO did not show significant
CAP-induced changes in nLF or HF/LF ratio
at either time point (Figure 2). Time domain
parameters and HF HRV did not change after
CAP exposure in participants supplemented
with either type of oil (data not shown). [See
Supplemental Material, Table 3 (http://dx.doi.
org/10.1289/ehp.1104472) for individual
values before and after each exposure for the
Holter parameters that changed.]
The duration of the QT interval (QTc
and QTp) was prolonged 20 hr after CAP
exposure in only the OO group (Figure 3
and Table 3). Conversely, the transmural dispersion of repolarization measure Tp-Te was
increased by CAP exposure in only the FO
group 20 hr after exposure, although there
was a trend (p = 0.07) for an increase in the
OO group (Figure 3). The ratio of Tp-Te/QT
was not altered by CAP exposure in either the
FO or OO groups.

Blood cells and lipids. Inhalation of CAP
did not cause significant changes in most
blood cell types in either supplement group,
as shown in Table 3. However, the percentage of neutrophils was significantly decreased
20 hr after CAP exposure in the OO group,
but not in the FO group (Figure 4).
Blood lipid levels in the participants
changed after 4 weeks of dietary supplementation: Very low-density lipoprotein (VLDL)
and triglyceride levels were higher in both the
FO and OO groups after supplementation,
high-density lipoprotein (HDL) levels were
lower in both groups, and low-density lipoprotein (LDL) levels were lower in the OO
group [see Supplemental Material, Table 4
(http://dx.doi.org/10.1289/ehp.1104472)].
Despite these changes that occurred in each
group during the 4-week supplementation
period, there were no statistical difference
in blood lipid levels between the FO and
OO groups at the end of the 4-week supplementation period except for VLDL in the
OO group, where levels were significantly
increased. Further data analysis showed that
there was no significant difference in these
markers after filtered air exposure compared
to pre-air levels in either supplementation
group (see Supplemental Material, Table 3).
However, exposure to CAP caused an
immediate increase in triglyceride and VLDL
in the OO group, but not in the FO group
(Figure 4 and Table 3); these changes were no
longer significant by the next morning. There
was a nonsignificant trend for an increase in
total cholesterol immediately after CAP exposure in the OO group (p = 0.09) but not the
FO group.

Table 3. Percent change from the filtered air exposure for individual end points per 100 µg/m3 of CAP.
FO (n = 16)
End points
HRV
nLF
HF/LF
QT
QTc
QTp
Tp-Te
Tp-Te/QT
Lipids
VLDL
LDL
HDL
Triglycerides
Total cholesterol
Blood cells
WBC
RBC
Platelets
Neutrophils
Lymphocytes
Monocytes

OO (n = 13)

Post-CAP

Follow-up

Post-CAP

Follow-up

–2.62 ± 1.85
3.67 ± 2.42

–0.74 ± 2.02
1.89 ± 2.77

7.41 ± 2.38*
–7.87 ± 3.12*

5.47 ± 2.60*
–2.97 ± 3.58

0.12 ± 0.15
0.44 ± 0.42
–0.48 ± 0.44
–0.66 ± 0.56

0.58 ± 0.26*
1.70 ± 0.55*
1.13 ± 0.62
–0.44 ± 0.59

0.05 ± 0.11
0.22 ± 0.33
0.65 ± 0.34
0.32 ± 0.43

0.08 ± 0.20
0.23 ± 0.43
1.17 ± 0.48*
0.72 ± 0.46

1.54 ± 1.95
–0.30 ± 0.81
–0.19 ± 0.72
1.27 ± 1.93
0.13 ± 0.50

–5.22 ± 2.97
1.08 ± 0.89
0.59 ± 0.68
–5.32 ± 2.96
0.45 ± 0.61

7.68 ± 2.55*
0.54 ± 1.05
–0.46 ± 0.93
7.40 ± 2.52*
1.10 ± 0.65

6.33 ± 3.82
–1.40 ± 1.15
–1.10 ± 0.87
6.00 ± 3.81
–0.57 ± 0.79

0.01 ± 1.04
–0.35 ± 0.38
0.26 ± 0.48
–0.47 ± 0.91
0.35 ± 1.42
–0.94 ± 3.12

2.81 ± 1.42
0.21 ± 0.43
0.59 ± 0.69
–0.02 ± 1.17
–0.83 ± 2.39
1.02 ± 1.99

0.06 ± 1.36
–0.12 ± 0.49
–0.41 ± 0.62
–1.10 ± 1.18
1.27 ± 1.85
0.60 ± 4.02

–2.06 ± 1.83
–0.75 ± 0.55
–0.30 ± 0.88
–3.05 ± 1.50*
4.47 ± 3.08
3.13 ± 2.56

Parameter estimates are summarized as mean ± SE.
*p < 0.05, compared to filtered air.
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Discussion
In this study, a brief exposure to inhaled
CAP resulted in significant autonomic, cardiac electrophysiological, and lipid changes
in healthy middle-aged participants taking
OO supplements but not in those supplemented with FO, suggesting that n‑3 FA is
protective against the physiological and biochemical effects of PM that are thought to
underlie adverse health outcomes described in
air pollution epidemiological studies.
Because of the number of persons worldwide who reside in areas with high air pollu
tion, a number of previous studies have sought
to identify commonly available agents that
could blunt the adverse effects associated with
air pollution exposure. Antioxidants and antiinflammatory agents have been evaluated as
strategies to block the respiratory effects of
ambient air pollution exposure [see review by
Romieu et al. (2008)]. We have previously
shown that vitamin C and E supplementation was effective in blunting the decrements
in lung functions but not the inflammatory responses to ozone in healthy adults
(Samet et al. 2001). Antioxidant statins were
reported to blunt the HRV effects of air pollution exposure in healthy aged adults who
were genetically susceptible to oxidative stress
[GSTM1 (glutathione S-transferase mu 1) null)
(Schwartz et al. 2005).
A number of studies have shown that
n‑3 FA can reduce mortality associated with
cardiovascular disease and that supplementation with n‑3 FA might protect vulnerable
populations from the adverse health effects
associated with air pollution exposure. The
American Heart Association (AHA) scientific
statement states that supplementation with
n‑3 FA decreases cardiac and all-cause mortality in persons with and without coronary heart
diseases and that higher doses of n‑3 FA can
OO, Post
OO, Follow-up
FO, Post
FO, Follow-up

QTc

lower serum triglyceride levels (Kris-Etherton
et al. 2002). Romieu et al. (2005) reported
that 2 g/day of FO supplementation appeared
to blunt the HRV changes associated with air
pollution exposure in nursing home residents,
resulting in significantly diminished time and
frequency domain HRV changes associated
with daily indoor PM2.5 exposure in participants, but not in participants supplemented
with soy oil. Our findings for changes measured after controlled CAP exposures were
consistent with those reported by Romieu
et al. (2005) In addition, our study examined
effects on a wider range of cardiovascular end
points, including cardiac repolarization indices
and blood lipid levels.
HRV is a marker of autonomic nervous
system control on the heart. Decreased HRV
has been associated with increased mortality
from sudden death and ventricular arrhythmia in both healthy and diseased individuals
(Kleiger et al. 1987; Lahiri et al. 2008; Tsuji
et al. 1996). Air pollution exposure is associated with decreases in HRV in older adults in
both epidemiological and controlled human
exposure studies (Devlin et al. 2003; Gold
et al. 2000; Pope et al. 2004). LF power has
been used as a marker of sympathetic modulation of heart rate, while the ratio of LF/
HF power has been used as an index of “sympatho-vagal balance” (Pagani et al. 1986). Our
data show that a brief exposure to CAP in
middle-aged participants supplemented with
OO altered the cardiac autonomic activity
by increasing nLF and decreasing the ratio of
HF/LF of HRV, and that the changes in nLF
persisted for at least 20 hr. These findings are
consistent with a previous study demonstrating
that CAP exposure alters the sympatho-vagal
balance (Devlin et al. 2003; Samet et al. 2009)
by increasing the sympathetic input to the
cardiovascular system, which might result in
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Figure 3. Effect of CAP exposure on indices of
cardiac repolarization. QTc, QTp, and Tp-Te were
analyzed in ECG recordings of participants at rest
before, immediately after exposure to filtered
air and CAP (Post), and again the next morning
(Follow-up) as described in “Methods.“ Data shown
are average changes per 100-µg/m3 increase in
CAP relative to the filtered air and 95% confidence
intervals.
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Figure 4. Effect of CAP exposure on plasma lipid
levels and blood percent of neutrophils. Blood percent of neutrophils, plasma triglycerides and VLDL
were measured before, immediately after exposure
to filtered air and CAP (Post), and again the next
morning (Follow-up) as described in “Methods.“
Data shown are average changes per 100-µg/m 3
increase in CAP relative to the filtered air and 95%
confidence intervals.

volume

cardiovascular stress including changes in heart
rate, cardiac contractility, high levels of circulating catecholamines, and vasoconstriction.
Epidemiological (Mozaffarian et al. 2008)
and clinical (O’Keefe et al. 2006) studies have
shown a positive association between cellular
content of n‑3 FA and more favorable HRV
measures. In the present study, plasma eicosa
pentaenoic acid and DPA concentrations were
significantly higher in the FO group than in the
OO group after 4 weeks of supplementation,
suggesting that one or both of these FAs contributes to the protective effect observed in this
study. The mechanism by which n‑3 FA influences HRV is thought to involve the modu
lation of adrenergic-mediated baroreceptor
activity or enhancement of vagal activity
(Mozaffarian et al. 2008; O’Keefe et al. 2006).
Our findings suggest that n‑3 FA improves
autonomic balance by suppressing PM-induced
increases in sympathetic nervous activity.
QT and QTc intervals have been used to
assess ventricular repolarization. Prolongation
of repolarization may indicate the likelihood
of increased arrhythmia vulnerability. Studies
have shown that air pollution exposure can
prolong cardiac repolarization. Epidemiological
investigation of patients with coronary artery
disease (Hampel et al. 2010) and controlled
exposure studies of healthy volunteers (Samet
et al. 2009) have shown increased QT intervals after exposure to PM, suggesting that PM
exposure may increase the risk of atrial and
ventricular arrhythmias. Furthermore, prolonged Tp-Te interval and Tp-Te/QT ratio
have been proposed as markers of ventricular arrhythmogenesis (Watanabe et al. 2004;
Yamaguchi et al. 2003) and a recent controlled
exposure study showed that exposure to CAP
and ozone increased Tp-Te in healthy adults
(Sivagangabalan et al. 2011). Clinical studies have suggested that fish or n‑3 FA intake
decreases the likelihood of a long QT interval
(Mozaffarian et al. 2006) and decreases susceptibility of the heart to atrial and ventricular
arrhythmia (Albert et al. 2002). In vitro studies have reported that n‑3 FA directly affect
cardiac electrophysiology by reducing myocyte
excitability and cytosolic calcium fluctuations
via inhibition of the voltage-dependent sodium
and L-type calcium channels and sodium/
calcium exchange currents (Xiao et al. 1995,
1997). In the present study, supplementation
of n‑3 FA blocked the PM-induced QT prolongation but not the dispersion of ventricular
repolarization (Tp-Te).
There were significant increases in trigly
cerides and VLDL immediately after CAP
exposure in participants supplemented with
OO, a finding that is consistent with our previous report showing that exposure to PM
elevated triglycerides and VLDL in asthmatic adults (Yeatts et al. 2007). In fact, PM
exposure has been associated with elevated
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levels of lipid peroxidation products in human
blood cells, plasma, and urine (Moller and
Loft 2010). Ambient air pollution exposure
has been associated with the development of
atherosclerosis in elderly men (Künzli et al.
2005) and apoE -/- mice (Sun et al. 2005).
Therefore, our data suggest the possibility that
the increased triglyceride and VLDL levels
associated with PM exposure is a potential
mechanism for atherosclerosis. Given that
the hypot riglyceridemic effects of n‑3 FA
are well established, and the U.S. Food and
Drug Administration (FDA) has approved an
n‑3 FA ethyl ester for the treatment of very
high triglyceride levels (Bays 2006), it is not
surprising that n‑3 FA appeared to attenuate CAP-induced increases in triglycerides
and VLDL immediately after exposure in
this study. The mechanism for these lipidlowering effects seems to involve the activation
of peroxisome proliferator-activated receptors
(Berger and Moller 2002).
The AHA recommends that everyone
eat at least two meals of oily fish per week,
and that those with a family or personal history of coronary heart disease supplement
their diet with FO tablets containing 600 mg
eicosapentaenoic acid and DHA daily to prevent cardiovascular disease. The dose of FO
supplementation in the present study was
consistent with the FDA recommendation
of 3.5 g FO/day. Supplementation with 3 g
FO/day (about 2,000 mg eicosapentaenoic
acid plus DHA) appeared to have a beneficial,
attenuating effect on the changes in HRV and
lipid levels induced by inhalation of PM 2.5
and PM0.1 air pollution particles in healthy
middle-aged adults.
There are limitations to this study.
This study did not use a standard crossover
design in which exposure to air and CAP
was randomized. A nonrandom design was
used because plasma concentrations of fatty
acids used in the supplements did not reach
equilibrium even after 4 weeks. To ensure that
each participant’s FA levels were comparable
during their air and CAP exposures, both
exposures were done in close proximity with
one another (a day apart). However, inhaled
particles are not cleared from the lung
for days, and thus CAP studies separate air
and CAP exposures by 2–4 weeks to account
for the long washout period of particles.
Because of these concerns, we chose to always
expose participants to air first. In addition,
conclusions derived from the small number of
participants included in the study may not be
applicable to the population as a whole.

Conclusions
A short exposure to CAP induced acute
changes in HRV, blood neutrophils, and lipids
that were attenuated in healthy middle-aged
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adults supplemented with FO, but not in those
supplemented with OO. Our findings suggest
that n‑3 FA supplements may offer protection
against the adverse cardiac and lipid effects
associated with air pollution exposure.
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